|
Volumn 26, Issue 8, 2007, Pages 900-904
|
Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
HUMAN;
LUNG CARCINOMA;
LYMPH NODE METASTASIS;
METHODOLOGY;
MIDDLE AGED;
NICK END LABELING;
PAGET NIPPLE DISEASE;
PATHOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION AND FORECASTING;
RADIOGRAPHY;
REMISSION;
SCINTISCANNING;
TREATMENT OUTCOME;
ADULT;
AGED;
APOPTOSIS;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CARCINOMA, LOBULAR;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
IN SITU NICK-END LABELING;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
POSITRON-EMISSION TOMOGRAPHY;
PREDICTIVE VALUE OF TESTS;
RADIOPHARMACEUTICALS;
REMISSION INDUCTION;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
EID: 48749111176
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|